Abstract submission deadline is Friday, December 15, 2017.
The CAHR 2018 Scientific Committee invites abstracts in the areas of: Basic Science, Clinical Science, Epidemiology and Public Health, and Social Sciences. In addition, and new for CAHR 2018, you can request that your abstract be considered under a “Key Populations” session theme.
- Abstract Submission Guidelines and Policies
- Abstract Subjects
- Scholarships and Awards
- Abstract Presentation Guidelines and Policies
- Submit your Abstract
- Edit your submitted Abstract(s)
Abstract Submission Guidelines and Policies
Submission of an abstract acknowledges your consent to the following:
- If accepted, your abstract may be published in a medical publication.
- If accepted as an oral presentation, your PPT presentation may be posted on the CAHR website post conference.
- If accepted as a poster presentation, you will display your poster at the Conference.
- You agree to prepare a “one-page media profile sheet” on your abstract for distribution to media if requested by CAHR.
- You agree to allow Rapporteurs to use all or part of your presentation or poster in the Rapporteur presentation at CAHR 2018.
Note: CAHR strives to promote excellence and innovation in HIV research in Canada. While CAHR welcomes all abstracts, those that offer new insights and are supported by researchers in Canadian universities, hospitals and other research institutions, are particularly encouraged.
Abstract Submission and Review Timeline
The deadline for abstract submission is Friday, December 15, 2017. The results of the peer review will be announced on February 2, 2018. The submitting author will be notified by email. Subsequent correspondence will be with the presenting author(s).
Presenting Author Registration
Presenting Authors must register to attend CAHR 2018. If you are not registered by the Presenting Author registration deadline of Monday, February 19, 2018 your abstract may not be included in the final program.
At the beginning of the abstract submission process, you will be asked to enter author information and affiliations.
Abstract Submiters and Presenters – CAHR strives to support the broadest numbers of researchers to participate in the Conference program. Any researcher who is submitting an abstract or presenting an abstract (oral or poster) must be a member of the research or investigation team.
Disclosure of Potential Conflict of Interest – If, within the past five years, an author or immediate family member has had a substantial personal financial relationship relating to the support of the abstract, this relationship must be described. Such relationships include salaries, ownerships, equity positions, stock options, royalties, consulting fees and honoraria for speaking, material support and other financial arrangements. During the abstract submission process, you will be asked to disclose any potential conflicts of interest. Find out more about CAHR’s Policy on Disclosure of Potential Conflicts of Interest.
Language of Abstract
Your abstract should be in English or French, and will be published in the language of submission.
Number of Submissions
There is a limit of two abstract submissions per presenting author.
Individual researchers are limited to presenting two abstracts per researcher during the Conference program. Individual researchers may not, however, present more than one oral abstract per track. If the author wishes to submit more than two (2) abstracts, the additional abstracts should be submitted by another researcher on the investigation team (that is, other than the principal investigator or presenting researcher). There is no limit to the number of times that a researcher’s name may appear as a member of a team of investigators on abstracts submitted to the conference. In cases where a researcher is involved in more than two abstracts or studies submitted for the Conference program, that researcher may be listed as the presenter only once for an oral session or twice for abstract posters.
Title and Abstract Length
The abstract title is limited to 140 characters. Please use Title Case (capital letters to start the principal words) for your abstract title instead of all CAPITAL or all small letters. Abstracts should be no more than 300 words in length, not including the title. Please note that abstracts will be truncated at 300 words in the Abstract Book if they run longer. Tables count as 50 words against the 300 word limit.
Please make sure you preview your abstract before submitting. We recommend you print the preview and proof the printed copy.
Prepare your abstract in a word processing software such as MS Word, WordPerfect, or a text editor such as MS Write. Do not use presentation software such as PowerPoint. If you incorporate a data table in your abstract, the table counts as 50 words against your 300 word total.
Preferred Presentation Format
Please select one of the following presentation options during online abstract submission:
A limited number of oral presentations are available at CAHR 2018, and therefore many authors requesting an Oral cannot be accommodated. The Scientific Committee will note the author’s preference for an Oral, but if not selected, authors will be offered a Poster presentation instead.
Canadian Connection Policy
Scientific abstracts submitted for CAHR conference program should demonstrate a clear Canadian connection.
To demonstrate a Canadian connection, an abstract would need to meet at least one or more of these criteria:
- one or more investigators are based in Canada, are Canadian residents or trained in Canada
- one or more funders are based in Canada, i.e. a Canadian funder, or other national or international funder (organization or individual) that is based in or operating in Canada
- one or more Canadian scientific research or other organizations based in Canada is involved or partnered in the research project
- at least some of the research population is resident in Canada
- at least some of the research activity is conducted in Canada
- the research builds extensively on existing Canadian research
- the evidence from the research is relevant, wholly or partially, to current issues and challenges specific to the HIV/AIDS response in Canada
- other connection such as the research was initiated, proposed or promoted by Canadian researcher(s) or institution(s).
Abstract Submission from outside of Canada
Over the last several years, there has been an alarming increase in the number of plagiarized abstracts submitted to the CAHR Conference. Due to this unfortunate situation, and in an effort to reduce the burden on abstract reviewers and Conference organizers, abstracts submitted from individuals from outside of Canada will be required to briefly describe the Canadian connection (as described above), and provide a Canadian HIV academic researcher as a reference to verify their work.
- HIV Virology (Viral and Host Factors)
- Immunology of HIV and Vaccines
- Mechanisms of HIV Pathogenesis (including animal models) and Co-Morbidities
- Host Genetics and Viral Evolution
- Antivirals, Microbicides and Mechanisms of HIV Resistance
- Eradication Strategies Towards an HIV Cure
- HIV Latency and Viral Reservoirs
- Molecular Mechanisms of Co-Infections
- Biomarkers and Diagnostics
- Clinical Trials and Observational Studies of Antiretrovirals and Other HIV Therapies
- Co-infections (including HCV, HBV, HPV, Syphilis, TB)
- Complications of Antiretroviral Therapy
- Early Treatment, Reservoirs, and Cure
- HIV and Aging and Comorbidities (changed from HIV and Aging – including CVD, Osteoporosis, Neurocognitive Effects)
- HIV in Children and Adolescents
- HIV in Vulnerable Populations and Global Health Issues
- HIV in Women and in Pregnancy
- HIV Prevention
- Mental Health Issues for HIV Positive Persons
- Opportunistic Infections and Malignancies
- Pharmacology, Pharmacokinetics and Pharmacoeconomics
- Substance Use and HIV
Epidemiology and Public Health Sciences
- Data Science: Use of Administrative Data, New Measurement Tools other Novel Data Sources in HIV Public Health Research
- Economic Evaluation of Policies, Programs or Interventions
- Epidemiology and Surveillance of HIV Co-infections
- Evaluations of Public Health Programs and Interventions
- HIV prevention for key populations
- HIV Program Science
- Interdisciplinary Epidemiology (Biological, Behavioural and Social) or Biopsychosocial Research
- Methodological Advances in Epidemiology, Public Health and Mathematical Modelling
- Policy Evaluations
- Process Advances and Lessons Learned in Complex or Community-based Public Health Research
- Public Health Ethics
- Social epidemiology of HIV infection (structural, social and individual determinants)
- Indigenous Health
- Combining Prevention Strategies: Social Science Perspectives
- Innovations in Community-Based Research
- Critical Social Theory: Advancements (in Understanding the HIV Epidemic)
- Engaging (with) Communities in HIV Research
- Diverse Experiences of Living with HIV
- Gay, Bisexual and other Men who have Sex with Men (MSM)
- Behavioral and Social Intervention Research
- Innovative Programming and Policy
- Diversities of Sexual Expression: Identities and Contexts
- Social, Structural and Systemic Drivers of HIV
- People who use Drugs and HIV
- The Health of African, Caribbean and Black Communities
- Criminalization, Law and Policy
- Women and HIV
- Trans identities and Communities
- Youth and Adolescents
- Intersecting Identities and HIV Contexts
The CAHR 2018 Scientific Committee invites abstracts in the areas of: Basic Science, Clinical Science, Epidemiology and Public Health, and Social Sciences. In addition, and new for CAHR 2018, you can request that your abstract be considered under a “Key Populations” session theme. By indicating your interest in participating in a Key Populations session, you agree to tailor your presentation to an audience from all tracks. Please note that indicating your interest here does not preclude your abstract from being accepted for your selected track sessions.
- HIV prevention and treatment interventions by, with, and for African, Caribbean and Black people
- HIV prevention and treatment interventions by, with, and for Indigenous communities
- New directions in HIV prevention and treatment among sexual and gender minorities*
- Intersecting vulnerabilities among people who use drugs
* sexual minorities include: gay, bi, queer, same gender loving and gender minorities include: trans and gender non-conforming people
Community Practice Research
The CAHR 2018 Scientific Committee also invites abstracts in the area of “Community Practice Research” to guide the development of a Special Session at the Conference. Participating in the “Community Practice Research” Special Session does not preclude your abstract from being accepted for an oral/poster presentation in your scientific track.
Scholarships and Awards
Academic Scholarships as well as New Investigator Awards will be presented to selected candidates. For application details, visit the Scholarships & Awards page. Please note that you must apply for scholarships and awards when submitting your abstract.
Abstract Presentation Guidelines and Policies
CAHR strives to support the broadest number of researchers to participate in the Conference program. Any researcher who is submitting an abstract or presenting an abstract (oral or poster) must be a member of the research or investigation team.
Individual researchers are limited to presenting two abstracts per researcher during the Conference program. Individual researchers may not, however, present more than one oral abstract per track. If the author wishes to submit more than two (2) abstracts, the additional abstracts should be submitted by another researcher as part of the investigation team (that is, other than the principal investigator or presenting researcher). There is no limit to the number of times that a researcher’s name may appear as a member of a team of investigators on abstracts submitted to the conference. In cases where a researcher is involved in more than two abstracts or studies submitted for the Conference program, that researcher may be listed as the presenter only once for an oral session or twice for abstract posters.
Exceptions to this policy may be considered on a case-by-case basis where in the opinion of the Track Chair and/or Conference Organizing Committee, such an exception may enhance the Conference program and/or advance HIV research and/or knowledge exchange. All decisions of the Conference Organizing Committee are final.
The oral presentations are scheduled on Friday, April 27th, Saturday, April 28th, and Sunday morning April 29th, 2018. You will be notified of your presentation time once your abstract is accepted for an oral presentation. Oral presentations are 10 minutes in length, and will be followed by 5 minutes for questions and answers. New Investigator Awards applicants will be reviewed during their presentation, and the awards recipients announced at the Closing Ceremonies of the Conference.
Posters will be presented on either Thursday, April 26 (Opening Reception), Friday, April 27, or Saturday, April 28, 2018 Information on poster viewing times, poster size, set-up and removal will be included in the abstract notification email.
Submit your Abstract(s)
If you would like to submit your abstract(s), visit the CAHR 2018 Abstract Submission site.
Edit your submitted Abstract(s)
If you would like to edit your submitted abstract(s), return to the CAHR 2018 Abstract Submission site, log back into your user account and edit your abstract(s). You can only edit your abstract until the abstract submission deadline.
Please email your questions on abstract submission to firstname.lastname@example.org.